A Randomized, Double-blind, Placebo-controlled, Single-dose, Dose-escalation Study of the Safety, Tolerability and Pharmacokinetics of CMX157 in Healthy Adult Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2015
At a glance
- Drugs Tenofovir exalidex (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B; HIV infections; Lipid metabolism disorders
- Focus Adverse reactions
- 01 Dec 2015 According to a ContraVir Pharmaceuticals media release, data from this study will be presented at the HEP DART 2015.
- 13 Dec 2010 Results presented at the 2101 Frontiers in Drug Development for Antiretroviral Therapies conference, according to a Chimerix media release
- 07 Nov 2010 Status changed from active, no longer recruiting to completed, according to a Chimerix media release.